Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3beta/mTOR signaling pathway.
about
Hypothyroidism and its rapid correction alter cardiac remodelingGlycogen synthase kinase 3 beta positively regulates Notch signaling in vascular smooth muscle cells: role in cell proliferation and survivalRenin angiotensin system modulates mTOR pathway through AT2R in HIVANThyroid Hormone Increases TGF-beta1 in Cardiomyocytes Cultures Independently of Angiotensin II Type 1 and Type 2 Receptors.Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2.Thyroid hormone stimulates NO production via activation of the PI3K/Akt pathway in vascular myocytesEmerging role of angiotensin type 2 receptor (AT2R)/Akt/NO pathway in vascular smooth muscle cell in the hyperthyroidism.Mouse cardiac acyl coenzyme a synthetase 1 deficiency impairs Fatty Acid oxidation and induces cardiac hypertrophy.The Impact of Overnutrition on Insulin Metabolic Signaling in the Heart and the KidneyCardiac insulin resistance and microRNA modulators.Adaptive mechanisms to compensate for overnutrition-induced cardiovascular abnormalities.Regulation of the instantaneous inward rectifier and the delayed outward rectifier potassium channels by Captopril and Angiotensin II via the Phosphoinositide-3 kinase pathway in volume-overload-induced hypertrophied cardiac myocytes.Preparation and Biological Activity of the Monoclonal Antibody against the Second Extracellular Loop of the Angiotensin II Type 1 Receptor.Losartan affects glomerular AKT and mTOR phosphorylation in an experimental model of type 1 diabetic nephropathy.Signaling mechanisms in thyroid hormone-induced cardiac hypertrophy.Serum microRNA profiling and bioinformatics analysis of patients with type 2 diabetes mellitus in a Chinese populationRole of thyroid hormones in ventricular remodeling.Vinexin-β protects against cardiac hypertrophy by blocking the Akt-dependent signalling pathway.Angiotensin II blockade: how its molecular targets may signal to mitochondria and slow aging. Coincidences with calorie restriction and mTOR inhibition.Inhibition of Receptor Interacting Protein Kinases Attenuates Cardiomyocyte Hypertrophy Induced by Palmitic Acid.S100A8/MYD88/NF-қB: a novel pathway involved in cardiomyocyte hypertrophy driven by thyroid hormone.MicroRNA-1 overexpression blunts cardiomyocyte hypertrophy elicited by thyroid hormone.Molecular characterization of thyroid hormone-inhibited atrial L-type calcium channel expression: implication for atrial fibrillation in hyperthyroidism.Renin inhibition and AT(1)R blockade improve metabolic signaling, oxidant stress and myocardial tissue remodeling.Cardiac microRNA-133 is down-regulated in thyroid hormone-mediated cardiac hypertrophy partially via Type 1 Angiotensin II receptor.Angiotensin II activation of mTOR results in tubulointerstitial fibrosis through loss of N-cadherin.Sexual dimorphism in autonomic changes and in the renin-angiotensin system in the hearts of mice subjected to thyroid hormone-induced cardiac hypertrophy.Cardioprotective effect of thyroid hormone is mediated by AT2 receptor and involves nitric oxide production via Akt activation in mice.AT1 receptor blockage impairs NF-κB activation mediated by thyroid hormone in cardiomyocytes.A Perfect sTORm: The Role of the Mammalian Target of Rapamycin (mTOR) in Cerebrovascular Dysfunction of Alzheimer's Disease: A Mini-Review.Angiotensin II type 2 receptor (AT2R) is associated with increased tolerance of the hyperthyroid heart to ischemia-reperfusion.Inhibition of Na/K-ATPase promotes myocardial tumor necrosis factor-alpha protein expression and cardiac dysfunction via calcium/mTOR signaling in endotoxemia.Chronic Akt activation accentuates aging-induced cardiac hypertrophy and myocardial contractile dysfunction: role of autophagy.Cardiac ACE2/angiotensin 1-7/Mas receptor axis is activated in thyroid hormone-induced cardiac hypertrophy.Oxidative stress and heart failure in altered thyroid States
P2860
Q27339180-2C76B46C-580A-449F-BBBD-9D93CBA820E7Q28583993-29F207BB-83AF-475A-9256-B883401BD4F1Q33850948-5EE23E5C-FD35-4649-A86F-700BB1836ABCQ33960840-84D09B17-0257-41F8-9F4F-DE8555299CEDQ34044364-4D95839D-7918-4F05-9F6D-DF65CEB124CBQ34541263-6AB08CC9-3E5E-4DD9-A38A-C57968A72A10Q34700791-48AB9ACF-10EF-4DC9-832F-2796FC4182C4Q34742779-29AE5619-4C3C-4243-B15C-E8171B53DB24Q35005356-4F895891-B4C8-4FE7-A3D7-1B5CDFF595CBQ35251097-FDD24ADC-B9EC-41D9-969F-7E424DE883B8Q35789287-BD1D73F2-3E13-41AE-8EFD-4CCDAA95DEFEQ36516502-11DD26C7-3EBB-4584-B3C1-1A9BEF00C484Q36556973-9026B6FC-33B3-4877-B145-2C9CE3E320FBQ37024574-D0B970E0-DC00-4A96-9017-DCD7F5EEE5A9Q37652498-85793838-C15D-4643-BA3B-AC44B18BEC51Q37720126-0F9325A2-BCF8-4EB7-B558-BABE63730FB1Q38285918-4DD57EEA-4B20-4F38-AF6C-9CDAC109AA17Q38317549-C650FDF0-C23C-4A83-B52E-C7A93548B5A3Q38454084-E581E5D0-EC97-4404-8401-7A2AB4F3B2A8Q38779902-4F656C26-7D2E-4756-BA38-0F749C64EB89Q38978641-1DB6D912-4D7D-4973-B345-BA056CA2FE3CQ39034552-ED222028-2F39-4A17-B57E-48202C3232F1Q39607963-685C289B-0DCD-4CB5-A598-06779094C3ECQ40262966-7AE82BE0-4256-4CED-8A39-7B3ED8CEA4A4Q40706803-EEA2B765-0BF5-46ED-A0E9-592648FB7137Q42043023-11D8909E-CB37-42FA-BC35-C88AD1FCAEBCQ45374246-E522E88A-3837-4D4E-8BF6-7B59648426B3Q47316917-E4013D31-6F59-4338-BC31-F791CD04EFA1Q47361706-7B7AC0F3-1869-44A1-92EF-302CB247416BQ47872250-7623584F-C43B-4716-B33E-1AC4A8728022Q50872186-DAC844EB-220F-4ACF-A1A7-807CAEDDF8F2Q54323110-A9A20AAB-05AE-480C-B0D6-21A24D5125EAQ54562272-ECBA48AE-C965-4668-B75C-4FF7E91E5532Q55294754-4B3D9568-4A98-4ECC-A2B1-BB026CFF1976Q58915024-DCA1FECC-B418-4FF2-9D83-51082EDE0A35
P2860
Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3beta/mTOR signaling pathway.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Angiotensin type 1 receptor me ...... -3beta/mTOR signaling pathway.
@en
Angiotensin type 1 receptor me ...... -3beta/mTOR signaling pathway.
@nl
type
label
Angiotensin type 1 receptor me ...... -3beta/mTOR signaling pathway.
@en
Angiotensin type 1 receptor me ...... -3beta/mTOR signaling pathway.
@nl
prefLabel
Angiotensin type 1 receptor me ...... -3beta/mTOR signaling pathway.
@en
Angiotensin type 1 receptor me ...... -3beta/mTOR signaling pathway.
@nl
P2093
P2860
P1476
Angiotensin type 1 receptor me ...... -3beta/mTOR signaling pathway.
@en
P2093
Gabriela Placoná Diniz
Marcela Sorelli Carneiro-Ramos
Maria Luiza Morais Barreto-Chaves
P2860
P2888
P304
P356
10.1007/S00395-009-0043-1
P577
2009-07-09T00:00:00Z
P6179
1038107376